Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood
- 1 May 2008
- journal article
- conference paper
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 165 (5), 604-609
- https://doi.org/10.1176/appi.ajp.2008.07091465
Abstract
Objective: Animal studies have shown that age at stimulant exposure is positively related to later drug sensitivity. The purpose of this study was to examine whether age at initiation of stimulant treatment in children with attention deficit hyperactivity disorder (ADHD) is related to the subsequent development of substance use disorders. Method: The authors conducted a prospective longitudinal study of 176 methylphenidate-treated Caucasian male children (ages 6 to 12) with ADHD but without conduct disorder. The participants were followed up at late adolescence (mean age=18.4 years; retention rate=94%) and adulthood (mean age=25.3; retention rate=85%). One hundred seventy-eight comparison subjects also were included. All subjects were diagnosed by blinded clinicians. The Cox proportional hazards model included the following childhood predictor variables: age at initiation of methylphenidate treatment, total cumulative dose of methylphenidate, treatment duration, IQ, severity of hyperactivity, socioeconomic status, and lifetime parental psychopathology. Separate models tested for the following four lifetime outcomes: any substance use disorder, alcohol use disorder, non-alcohol substance use disorder, and stimulant use disorder. Other outcomes included antisocial personality, mood, and anxiety disorders. Results: There was a significant positive relationship between age at treatment initiation and non-alcohol substance use disorder. None of the predictor variables accounted for this association. Post hoc analyses showed that the development of antisocial personality disorder explained the relationship between age at first methylphenidate treatment and later substance use disorder. Even when controlling for substance use disorder, age at stimulant treatment initiation was significantly and positively related to the later development of antisocial personality disorder. Age at first methylphenidate treatment was unrelated to mood and anxiety disorders. Conclusions: Early age at initiation of methylphenidate treatment in children with ADHD does not increase the risk for negative outcomes and may have beneficial long-term effects.Keywords
This publication has 29 references indexed in Scilit:
- Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up studyPsychological Medicine, 2006
- Attention-Deficit/Hyperactivity Disorder and Early-Onset Substance Use DisordersJournal of Child and Adolescent Psychopharmacology, 2005
- Does Stimulant Treatment Place Children at Risk for Adult Substance Abuse? A Controlled, Prospective Follow-up StudyJournal of Child and Adolescent Psychopharmacology, 2003
- Altered responsiveness to cocaine in rats exposed to methylphenidate during developmentNature Neuroscience, 2001
- Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-Deficit/Hyperactivity DisorderPublished by American Academy of Pediatrics (AAP) ,2001
- Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a reviewPharmacology Biochemistry and Behavior, 2001
- Long-Term Effects of Stimulant Medications on the Brain: Possible Relevance to the Treatment of Attention Deficit Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology, 2001
- A longitudinal study of children of alcoholics: Predicting young adult substance use disorders, anxiety, and depression.Journal of Abnormal Psychology, 1999
- Explaining the relation between IQ and delinquency: Class, race, test motivation, school failure, or self-control?Journal of Abnormal Psychology, 1993
- Classroom observation code for hyperactive children: A replication of validity.Journal of Consulting and Clinical Psychology, 1980